Hospital
Sutter Valley Hospitals
Sutter Valley Hospitals was paid $11.20M by Medicaid between Jan 2018 and Dec 2024, across 141 billing codes. Its largest line is 0450, Emergency room services — 22% of everything it billed.
33Billing provider infoSUTTER VALLEY HOSPITALS
JACKSON, CA 95642
JACKSON, CA 95642
33aNPI1447494323assigned 04/23/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.20M
24GClaims238,148
24DCodes billed141
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#169 of 410
Median peer was paid$6.90M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,218 | $1.45M | |
| 2019 | 32,633 | $1.30M | |
| 2020 | 24,838 | $1.10M | |
| 2021 | 33,956 | $1.63M | |
| 2022 | 38,801 | $2.03M | |
| 2023 | 42,742 | $2.19M | |
| 2024incomplete | 30,960 | $1.51M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 22% | 29,473 | 25,437 | $2.42M |
| 99199 | Unlisted special service, procedure or report | 12% | 16,724 | 14,255 | $1.29M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.8% | 2,198 | 2,089 | $652K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.5% | 5,232 | 4,660 | $392K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 1,876 | 1,770 | $356K |
| 0250 | 3.1% | 6,090 | 3,521 | $343K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.0% | 4,740 | 4,553 | $333K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.5% | 4,810 | 4,125 | $280K |
| 80053 | Comprehensive metabolic panel | 2.3% | 9,609 | 8,557 | $263K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.3% | 1,195 | 1,171 | $252K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.2% | 2,727 | 2,477 | $243K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.0% | 1,182 | 1,153 | $228K |
129 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 5,668 | $206K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.8% | 5,467 | $206K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 2,106 | $192K |
| J3490 | Unclassified drugs | 1.7% | 8,260 | $187K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 4,821 | $179K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.5% | 1,382 | $165K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 14,249 | $156K |
| 82077 | 1.3% | 1,018 | $148K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 1,375 | $133K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 1.1% | 5,640 | $128K |
| Z7502 | 1.0% | 3,083 | $115K | |
| 0270 | <1% | 2,075 | $110K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 542 | $105K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,050 | $101K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,215 | $95K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 318 | $90K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,706 | $87K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,964 | $85K |
| 83880 | <1% | 2,417 | $81K | |
| 84484 | <1% | 5,237 | $70K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,905 | $70K |
| 96376 | <1% | 434 | $68K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 663 | $61K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,044 | $53K |
| 99283 | Emergency room visit (moderate) | <1% | 297 | $44K |
| 80179 | <1% | 358 | $43K | |
| 80143 | <1% | 353 | $43K | |
| 99284 | Emergency room visit (serious) | <1% | 263 | $42K |
| 73630 | <1% | 1,046 | $42K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 435 | $42K |
| 83690 | <1% | 4,080 | $42K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,366 | $41K |
| 73610 | <1% | 932 | $40K | |
| 73030 | <1% | 950 | $39K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,116 | $36K |
| 81001 | <1% | 5,666 | $35K | |
| 80076 | <1% | 2,966 | $34K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,366 | $32K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,666 | $31K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 115 | $31K |
| 81025 | <1% | 2,338 | $30K | |
| 73110 | <1% | 593 | $30K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,195 | $28K |
| 0510 | <1% | 539 | $28K | |
| 99285 | Emergency room visit (most serious) | <1% | 93 | $28K |
| 87040 | <1% | 1,317 | $24K | |
| 73130 | <1% | 506 | $22K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,366 | $22K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,830 | $21K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 712 | $21K |
| 73564 | <1% | 465 | $20K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 224 | $19K |
| 83735 | <1% | 2,014 | $19K | |
| 76830 | Ultrasound, transvaginal | <1% | 171 | $19K |
| 82803 | <1% | 767 | $18K | |
| 85379 | <1% | 1,174 | $18K | |
| 81003 | <1% | 4,007 | $18K | |
| 83605 | <1% | 1,055 | $15K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,306 | $13K |
| 0760 | <1% | 220 | $12K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 106 | $12K |
| 85610 | <1% | 2,209 | $11K | |
| 86140 | <1% | 1,423 | $10K | |
| 87077 | <1% | 738 | $10K | |
| 73562 | <1% | 212 | $10K | |
| 87186 | <1% | 923 | $10K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 993 | $8K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 97 | $7K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 927 | $7K |
| 87634 | <1% | 97 | $7K | |
| 87430 | <1% | 484 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 15 | $7K |
| 93971 | <1% | 55 | $7K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 14 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 101 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 99 | $6K |
| 87081 | <1% | 488 | $5K | |
| 71250 | <1% | 29 | $5K | |
| 73502 | <1% | 95 | $5K | |
| 72100 | <1% | 131 | $5K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 456 | $5K |
| 85730 | <1% | 576 | $4K | |
| 76641 | <1% | 54 | $4K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 19 | $4K |
| 87400 | <1% | 432 | $4K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 346 | $4K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 114 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 140 | $3K |
| 90715 | <1% | 43 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 55 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 153 | $2K |
| 84703 | <1% | 802 | $2K | |
| 72110 | <1% | 24 | $1K | |
| 87070 | <1% | 106 | $1K | |
| 82947 | <1% | 99 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,456 | $1K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 56 | $1K |
| 71020 | <1% | 27 | $1K | |
| Z7610 | <1% | 124 | $1K | |
| 87075 | <1% | 74 | $1K | |
| Z9725 | <1% | 24 | $1K | |
| 59025 | Fetal non-stress test | <1% | 44 | $981.03 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 113 | $939.88 |
| 87581 | <1% | 15 | $861.72 | |
| 87486 | <1% | 15 | $861.72 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 25 | $820.56 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 15 | $816.59 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 15 | $795.85 |
| 87205 | <1% | 100 | $735.90 | |
| J2704 | Injection, propofol, 10 mg | <1% | 40 | $591.17 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 56 | $474.92 |
| 84702 | <1% | 42 | $341.65 | |
| 85652 | <1% | 100 | $290.86 | |
| 73140 | <1% | 13 | $233.54 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 193 | $230.40 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 178 | $222.46 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 41 | $207.83 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 151 | $189.56 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 28 | $188.91 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 29 | $181.78 |
| 87420 | <1% | 14 | $150.93 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 17 | $117.86 |
| S0028 | Injection, famotidine, 20 mg | <1% | 12 | $90.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 14 | $84.02 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 47 | $61.17 |
| 86901 | <1% | 12 | $55.14 | |
| 86900 | <1% | 16 | $46.10 | |
| 80061 | Lipid panel | <1% | 12 | $19.25 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 13 | $8.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCONFORTI, JAMES (PRESIDENT/CEO)
Parent organizationSUTTER VALLEY HOSPITALS
| Provider | Location | Paid |
|---|---|---|
| Sutter Valley Hospitals | Roseville, CA | $81.16M |
| Sutter Valley Hospitals | Vallejo, CA | $33.28M |
| Sutter Valley Hospitals | Davis, CA | $20.04M |
| Sutter Valley Hospitals | Auburn, CA | $15.54M |
| Sutter Valley Hospitals | Sacramento, CA | $3.16M |
| Sutter Valley Hospitals | Auburn, CA | $165K |
| Sutter Valley Hospitals | Auburn, CA | $25K |
| Sutter Valley Hospitals | Sacramento, CA | $71.31 |
| Sutter Valley Hospitals | Roseville, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.